drugset / Trial / NCT02264106
Influence of Pantoprazole on the Pharmacokinetics of Fradafiban After Multiple Oral Doses of Lefradafiban Over 5 Days in Healthy Subjects
RandomizedCrossoverOpen-labelTreatment
Summary
To assess the absorption of 30 mg Lefradafiban in two formulations, each under physiological conditions and with 40 mg Pantoprazole
Timeline
- Start
- 1998-04
- Primary completion
- 1998-06
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lefradafiban | Small molecule | 30 mg | Oral |
| Subject | Pantoprazole | Other / unclassified | 40 mg | — |
Indications
No indication recorded.